Aller au contenu

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of NUT carcinoma and other cancers: results of a phase I/II open-label, dose escalation study

Nom du journal : Int J Cancer

Année : 2021

Volume : 150

Page de départ : 993

Page de fin : 1006

Auteurs: de Bono JS, Piha-Paul SA, Shapiro GI, Hemming ML, Plummer R, Moreno V, Cousin S, Le Tourneau C, Im SA, Cassier PA, Sablin MP, Italiano A, Blay JY, Braña Garcia I, Trigo J, Hann CL, Azad AA, French CA, Keedy VL, Ferron-Brady G, Wyce A, Khaled A, Datta A, Foley SW, McCabe MT, Wu Y, Horner T, Kremer BE, Dhar A, O'Dwyer PJ,